（照片）          姓　名：张波

职　称：研究员

导师类别：

E-mail：996503@hainanu.edu.cn

一、个人基本情况

张波，男，博士，研究员。

二、教育工作情况

2022.12-2023.08，北京大学，公共卫生学院全球卫生学系，博士后

2021.01-2022.12，北京大学，基础医学院病原微生物学系，博士后

2017.09-2021.01，北京大学，流行病与卫生统计学系，博士

2013.09-2016.06，山东大学，软件工程系，硕士

2007.09-2011.06，山东财经大学，计算机科学与技术系，学士

三、科研情况

主持科技部“十三五”科技冬奥重点专项子课题、“十四五”生物与信息融合重点专项子课题、国家自然科学基金青年基金、中国博士后科学基金等纵向课题。发表论文33篇，其中以第一作者或通讯作者发表SCI论文16篇。

四、研究领域

大数据驱动的传染病及药物滥用预防与控制

五、社会兼职

担任The Lancet Child & Adolescent Health、The Lancet Regional Health - Western Pacific、Emerging Microbes & Infections、International Journal of Drug Policy、Frontiers in Public Health、American Journal of Infection Control审稿人。

担任《环境卫生学杂志》青年编委。

六、代表性项目

1.科技部，“十四五”国家重点研发计划“生物与信息融合（BT与IT融合）”重点专项，2022YFF1203204，病毒基因组未来变异演化预测与预警技术研发，2023/01-2025/12，140万，在研，子课题主持。

2.国家自然科学基金青年基金，72104008，大型体育赛事新冠疫情预警预测模型研究，2022/01-2023/12，20万，在研，主持。

3.中国博士后科学基金，2022M710250，大数据驱动的我国肺结核复发防控策略研究，2022/01-2022/12，8万，结题，主持。

4.科技部，国家重点研发计划“科技冬奥”重点专项，2021YFF0306001， 疫情风险及其外溢效应对冬奥会的影响与对策研究，2021/04-2022/06，5万，结题，子课题主持。

5.北京大学首都发展研究院，基于北京市吸毒人员全景数据集的毒情综合管理模式研究，2018/10-2019/03，2万，结题，主持。

七、代表性成果

1. 张波，闫翔宇，张翔宇，贾忠伟. 老年人麻醉药品和精神药品滥用现状及预防策略研究进展. 中华流行病学杂志, 2020(04): 615-620.

2. [Correspondence Letter] Zhang B#*, Qin S. Mental health at the forefront of women-centred health-care systems. Lancet. 2023 Aug 5;402(10400):445. doi: 10.1016/S0140-6736(23)00635-9.

3. [Abstract] Zhang B#, Lu Z, Wang L, et al. Tracking HIV infection and networks of drugs users in China: a national series, cross-sectional study. Lancet, 2018, 392.

4. [Correspondence Letter] Yan X, Jia Z, Zhang B*. Evaluating the risk compensation of HIV/AIDS prevention measures. Lancet Infectious Diseases. 2022 Apr;22(4):447-448. doi: 10.1016/S1473-3099(22)00151-7.

5. [Comment] Yan X, Qin S, Zhang B*. Take action to mitigate the impact of the COVID-19 pandemic on HIV prevention and control. Lancet Reg Health West Pac. 2023 Apr 10;36:100767. doi: 10.1016/j.lanwpc.2023.100767.

6. [Article] Wang X, Cai Y, Zhang B*, Zhang X, Wang L, Yan X, Zhao M, Zhang Y*, Jia Z. Cost-effectiveness analysis on COVID-19 surveillance strategy of large-scale sports competition. Infectious Diseases of Poverty. 2022 Mar 18;11(1):32. doi: 10.1186/s40249-022-00955-3.

7. [Article] Zhang B#, Yan X, Li Y, Zhu H, Liu Z, Lu Z, Jia Z. Epidemic of HIV infection among persons who inject drugs in mainland China: a series, cross-sectional study. Harm Reduction. 2021 Jun 12;18(1):63. doi: 10.1186/s12954-021-00511-6.

8. [Letter] Yan X, Wang X, Wang L, Zhang B*, Jia Z. Refocus attention on HIV/AIDS: it was neglected during the COVID-19 pandemic. Clinical Microbiology and Infection. 2022 Jun 18:S1198-743X(22)00324-X. doi: 10.1016/j.cmi.2022.06.011.

9. [Article] Zhang B#, Yan X, Li Y, Zhu H, Lu Z, Jia Z. Trends in Methamphetamine Use in the Mainland of China, 2006-2015. Frontiers in Public Health. 2022 Apr 28;10:852837. doi:10.3389/fpubh.2022.852837.

10. [Article] Zhang B#, Yan X, Li Y, Zhu H, Lu Z, Jia Z. Association between Drug Co-use Networks and HIV Infection: A Latent Profile Analysis in Chinese Mainland[J]. Fundamental Research. 2021 Sep 1;5;552-558.

11. [Article] Zhang B#, Yan XY, Li YJ, Liu ZM, Lu ZH, Jia ZW. Epidemics of HIV Infection among Heavy Drug Users of Depressants Only, Stimulants Only, and Both Depressants and Stimulants in Mainland China: A Series, Cross-Sectional Studies. International Journal of Environmental Research and Public Health. 2020 Jul 29;17(15):5483. doi: 10.3390/ijerph17155483.

12. [Proposal] Lei Wang, Xiangyu Yan, Lin Mei, Zhongwei Jia, Bo Zhang*. Effect of e-health interventions on HIV prevention: a protocol of systematic review and meta-analysis. Systematic Reviews.

13. [Review] Yan X, Fang Y, Li Y, Jia Z, Zhang B*. Risks, Epidemics, and Prevention Measures of Infectious Diseases in Major Sports Events: Scoping Review. JMIR Public Health Surveill. 2022 Dec 2;8(12):e40042. doi: 10.2196/40042.

14. [Article] Yan X, Xiao W, Zhou S, Wang X, Wang Z, Zhao M, Li T, Jia Z, Zhang B*, Shui T*. A four-generation family transmission chain of COVID-19 along the China-Myanmar border in October to November 2021. Front Public Health. 2022 Nov 17;10:1004817. doi: 10.3389/fpubh.2022.1004817.

15. [Letter] Zhang P, Yan XY, Li YJ, Zhang B*, Wang J*. CD4+ T Cell Recovery among Patients with HIV/AIDS who Received Highly Active Antiretroviral Therapy Regularly in Chongqing, China: An Ambispective Cohort Study. Biomedical and Environmental Sciences. 2022 Mar 20;35(3):254-258. doi: 10.3967/bes2022.035.

16. [Article] Yan X, Chang L, Wang Z, Hao L, Jia Z, Zhang B*, Shui T*. Exploring the Bridge Cases' Role in the Transmission of the SARS-CoV-2 Delta Variant - Ruili City, Yunnan Province, China, July-September 2021. China CDC Weekly. 2021 Dec 3;3(50):1065-1070.

17. [Article] Yan X, Wang X, Zhang X, Wang L, Zhang B*, Jia Z*. The Epidemic of Sexually Transmitted Diseases Under the Influence of COVID-19 in China. Frontiers in Public Health. 2021 Dec 16;9:737817. doi: 10.3389/fpubh.2021.737817.